How should a 46-year-old woman with a history of migraine with aura who has experienced an increase in migraine frequency over the past 6 weeks, new aura symptoms (left‑side numbness, expressive aphasia, visual changes), nausea/vomiting, and recent changes in hormone therapy (topical testosterone and an estrogen patch) be evaluated and managed?

Immediate Discontinuation of Estrogen Therapy and Urgent Neurological Evaluation Required

This patient requires immediate discontinuation of her estrogen patch and urgent neurological evaluation to rule out migrainous infarction or stroke, given her new-onset focal neurological symptoms (left-sided numbness, expressive aphasia) in the setting of migraine with aura and recent estrogen initiation.

Critical Safety Concern: Estrogen and Migraine with Aura

The combination of migraine with aura and estrogen therapy creates a significantly elevated stroke risk that demands immediate action:

• Estrogen is contraindicated in migraine with aura 1. The FDA drug label explicitly warns that estrogen increases stroke risk, and combined with migraine with aura, this risk multiplies dangerously 2.
• Research confirms that estrogen-containing hormonal therapy significantly increases ischemic stroke risk specifically in women with migraine with aura 2, 3.
• Her new aura symptoms (left-sided numbness, expressive aphasia) lasting 30-45 minutes represent red flags that could indicate either severe migraine aura or actual ischemic events 4, 5.

Stop the estrogen patch immediately and do not restart it. The topical testosterone can continue as it does not carry the same stroke risk 6.

Urgent Evaluation Protocol

Before addressing migraine management, rule out stroke:

1. Obtain urgent brain MRI with diffusion-weighted imaging to exclude migrainous infarction or ischemic stroke 5, 7

2. Assess for new or atypical features that distinguish dangerous pathology from typical aura:

   • Sudden (not gradual) onset suggests stroke, not aura
   • Symptoms lasting >60 minutes warrant imaging 4, 7
   • Bilateral symptoms or symptoms in a vascular territory suggest TIA 4
   • Her left-sided numbness with aphasia could represent either prolonged aura or actual infarction 5

3. Complete cardiovascular workup if imaging shows infarction: echocardiogram, carotid imaging, hypercoagulability panel 5

Acute Migraine Treatment Optimization

Her current regimen (800mg ibuprofen + caffeine) is inadequate for moderate-to-severe migraine with aura:

Upgrade to combination therapy immediately 8:

• Add a triptan to her NSAID regimen (strong recommendation, moderate-certainty evidence) 8
• Specific options: sumatriptan, rizatriptan, or zolmitriptan taken at headache onset (not during aura) 9, 4
• Critical timing: Start the triptan when headache begins, not during the aura phase 4, 2
• For nausea/vomiting: add metoclopramide or prochlorperazine 10, 9

Common pitfall to avoid: Do not use triptans during the aura phase—wait until headache starts 4, 2. However, she can take her NSAID during aura to potentially reduce headache severity 2.

Preventive Therapy Initiation

With increased frequency over 6 weeks, she now meets criteria for preventive therapy 9:

Start with first-line oral preventive medication 8, 11:

• Propranolol 80-240mg/day OR Metoprolol (β-blockers are first-line, cost-effective) 9, 11
• Alternative first-line options if β-blockers contraindicated:
  • Amitriptyline 30-150mg/day 9, 11
  • Venlafaxine (SNRI) 11
  • Valproate 800-1500mg/day 9, 11

Titrate slowly over 2-3 months for adequate trial before declaring failure 9.

Reserve CGRP monoclonal antibodies or gepants only if she fails trials of β-blockers, amitriptyline, venlafaxine, AND valproate due to substantially higher cost without superior efficacy 11.

Hormone Management Going Forward

Since she's perimenopausal (age 46) with worsening migraines:

For vasomotor symptoms without estrogen:

• Consider venlafaxine or escitalopram—these treat both migraine prevention AND hot flashes 3
• If hormones absolutely necessary: progestogen-only options (levonorgestrel IUD or continuous oral progestogen) with optional low-dose transdermal estrogen ONLY if migraine pattern stabilizes and aura resolves 3, 12

Never use cyclical progestogens—they worsen migraine 3.

Medication Overuse Monitoring

Warn about medication overuse headache:

• Limit acute treatment to <10 days/month for triptans 8, 13
• Limit NSAIDs to <15 days/month 8, 13
• Her current twice-weekly use is acceptable, but monitor closely as frequency increases

Key Clinical Pitfalls

1. Do not dismiss new aura symptoms as "just migraine"—left-sided numbness with aphasia in a woman on estrogen requires imaging 4, 5
2. Do not continue estrogen in migraine with aura—this is an absolute contraindication due to stroke risk 1, 2
3. Do not use triptans during aura—wait for headache phase 4, 2
4. Do not skip preventive therapy—increasing frequency demands prophylaxis 9
5. Do not start with expensive CGRP therapies—use cost-effective first-line agents first 11